Your browser doesn't support javascript.
loading
Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles.
Li, Suping; Zhang, Yinlong; Ho, Shih-Hsin; Li, Bozhao; Wang, Meifang; Deng, Xiongwei; Yang, Na; Liu, Guangna; Lu, Zefang; Xu, Junchao; Shi, Quanwei; Han, Jing-Yan; Zhang, Lirong; Wu, Yan; Zhao, Yuliang; Nie, Guangjun.
Afiliação
  • Li S; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Zhang Y; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
  • Ho SH; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Li B; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
  • Wang M; State Key Laboratory of Urban Water Resource and Environment, School of Environment, Harbin Institute of Technology, Harbin, China.
  • Deng X; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Yang N; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Liu G; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Lu Z; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Xu J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Shi Q; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Han JY; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
  • Zhang L; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Wu Y; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
  • Zhao Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
  • Nie G; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
Nat Biomed Eng ; 4(7): 732-742, 2020 07.
Article em En | MEDLINE | ID: mdl-32572197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombina / Doxorrubicina / Sistemas de Liberação de Medicamentos / Tratamento Farmacológico / Nanopartículas / Infarto / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombina / Doxorrubicina / Sistemas de Liberação de Medicamentos / Tratamento Farmacológico / Nanopartículas / Infarto / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article